'Europe Awaits Decision on Patents, hESCs, and Morality', by Andrew Sharples

Partner and head of EIP Life, Andrew Sharples, has an article published in the latest edition of US biotech journal Genetic Engineering and Biotechnology News (GEN).

The article entitled Europe Awaits Decision on Patents, hESCs, and Morality, discusses a pending court case at the Court of Justice of the European Union (CJEU) on the patentability of human embryonic stem cells (hESCs).

To read the article in full, click here.